Summaries for patients. A new anti-inflammatory therapy (Infliximab) for complicated sarcoidosis.
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D003967:Diarrhea / Q000150:complications / Q000188:drug therapy; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D000069285:Infliximab; D008171:Lung Diseases / Q000150:complications / Q000188:drug therapy*; D018908:Muscle Weakness / Q000150:complications / Q000188:drug therapy; D012507:Sarcoidosis / Q000150:complications / Q000188:drug therapy*; D013927:Thrombosis / Q000139:chemically induced; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab